Therapy of thoracic malignancies

Thematic Poster Session
Chairs: N. Dickgreber (Hannover, Germany), P. E. Postmus (Amsterdam, The Netherlands)
Lung volume reduction surgery in patients with early-stage lung cancer: a single-center study
D. Lardinois, I. Opitz, E. Grebski, V. Rousson, E. Russi, W. Weder (Zurich, Switzerland)
Congress or journal article abstract
Congress or journal article abstract
Validating lung cancer multi-disciplinary meetings; are decisions being followed?
D. Pandit, J. Mcfadden, K. Srinivasan, H. Moudgil (Telford, Shropshire, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Clinical study for monochemotherapy of amrubicin, a topoisomerase II inhibitor, in patients with previously treated small cell lung cancer
S. Morita, K. Irisa, T. Sano, T. Yamada, M. Ida, T. Hirata (Shizuoka, Japan)
Congress or journal article abstract
Congress or journal article abstract
The 7-year results of the surgical treatment of non-small cell lung cancer (NSCLC) patients and the influence of neoadjuvant treatment
J. Skrickova, M. Tomiskova, A. Svobodnik, B. Kadlec, I. Vasutova, L. Babickova, I. Hanke, T. Horvath, J. Vomela, P. Turcani (Brno, Czech Republic)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Locally advanced inoperable non-small cell lung cancer (NSCLC) treated by weekly paclitaxel/carboplatin chemotherapy with concomitant radiotherapy
I. Spasova, R. Pajdlhauser, M. Marel, J. Musil (Prague, Czech Republic)
Congress or journal article abstract
Congress or journal article abstract
Dexamethasone improves antiemetic control in lung cancer patients treated with chemotherapy
T. Sarcev, N. Secen, D. Povazan, A. Sabo, D. Bursac, M. Kakas, A. Milovancev (Sremska Kamenica, Vojvodina, Novi Sad, Serbia And Montenegro)
Congress or journal article abstract
Congress or journal article abstract
Clinical experiences of amrubicin hydrochloride monotherapy in extensive-disease small cell lung cancer
M. Kawakami, S. Ohno, A. Tsujita, M. Bando, Y. Sugiyama (Tochigi, Japan)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Does large airway intervention for patients with malignant disease result in early clinical benefit
B. Madden, M. Wilde, A. Sheth, J. Myerson, M. O‘brien (London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
The estimations of two regimenes of radiation of brain metastases in patients with primary lung cancer
G. Gligorijevic, N. Jovanovic Korda, D. Grujicic (Belgrade, Serbia And Montenegro)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Postoperative adjuvant treatment in stage III NSCLC
S. Adzemovic, D. Subotic, G. Radosavljevic Asic (Belgrade, Serbia And Montenegro)
Congress or journal article abstract
Congress or journal article abstract
Gemsitabine plus cisplatine therapy in local advanced NSCLC
B. Komurcuoglu, H. Aydogan, M. Gayaf, E. Yalniz, E. Ozden (Izmir, Turkey)
Congress or journal article abstract
Congress or journal article abstract
Zoledronic acid limits experimental malignant pleural effusion
G. T. Stathopoulos, C. Moschos, A. Kollintza, I. Psallidas, H. Loutrari, S. Magkouta, H. Petrocheilou, P. Theodoropoulou, S. A. Papiris, C. Roussos, I. Kalomenidis (Athens, Greece)
Congress or journal article abstract
Congress or journal article abstract
Management of outpatients referred to a lung cancer diagnostic clinic
D. Sanchez, F. Andreo, A. Ruiz, J. Roca, E. Monso (Badalona, Catalonia, Spain)
Congress or journal article abstract
Congress or journal article abstract
Pathway of lung cancer presentation – does it affect management?
K. Lilley, D. Saralaya, D. Newton, A. Dwarakanath, R. Mustafa, B. Jacob (Bradford, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Retrospective evaluation of 992 hospitalised malignant patients
A. Ustamujic, H. Zutic, A. Hadziredzepovic, V. Cukic, V. Lovre, I. Sladic (Sarajevo, Bosnia And Herzegovina)
Congress or journal article abstract
Congress or journal article abstract
Biweekly carboplatin-gemcitabine administration in elderly patients with advanced non-small cell lung cancer (NSCLC). A phase II study
I. Gkiozos, N. Katirtzoglou, K. Pantazopoulos, D. Stathopoulos, I. Tzanou, E. Chondrou, A. Zalonis, E. Katirtzoglou, K. Giannopoulos, K. Syrigos (Athens, Greece)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
PET scan in stage IA lung cancer
H. Burhan, K. Mohan, P. Littler, J. McShane, A. McIver, M. Ledson, M. Walshaw (Liverpool, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Three drug regimen in SCLC-ED patients: a phase II study
A. Charpidou, N. Katirtzoglou, I. Gkiozos, C. Alamara, I. Tzanou, K. Dilana, E. Kotteas, I. Tourkantonis, K. Syrigos (Athens, Greece)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Chemotherapy with carboplatin and gemcitabine in patients with non resectable stages of non-small cell lung cancer (non-SCLC)
P. Gudiel Arriaza, T. Gonzalez Budiño, C. Escudero Bueno, A. González Panizo, J. Martinez González Del Río (Oviedo, Asturias, Oviedo, Spain)
Congress or journal article abstract
Congress or journal article abstract
The relationship between hemoptysis and the features of tumors in primary lung cancer
F. Sahin, G. Karapinar, M. Bayraktaroglu, D. Görgün, G. Özgül, F. Arkin, P. Yildiz (Istanbul, Turkey)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster